The A 2A adenosine receptor (A 2A AR) mediates anti-inflammatory actions of adenosine in a variety of cell types. LPS (lipopolysaccharide) was reported to induce a small (< 2-fold) increase in the expression of A 2A AR mRNA in human monocytes and monocytic cell lines. We investigated the effects of LPS on the expression of adenosine receptor mRNAs in primary mouse IPM (intraperitoneal macrophages), human macrophages and Wehi-3 cells. Treatment with 10 ng/ml LPS for 4 h produced a > 100-fold increase in A 2A AR mRNA. LPS-induced increases in mRNA for A 2A AR and TNFα (tumour necrosis factor α) are reduced by 90 % in IPM pretreated with the NF-κB (nuclear factor κB) inhibitor, BAY 11-7082 {(E)3- [(4-methylphenyl)sulphonyl]-2-propenenitrile; 10 µM}. In Wehi-3 cells exposed to LPS, A 2A AR and A 2B AR transcripts are elevated by 290-and 10-fold respectively, the A 1 AR transcript is unchanged and the A 3 AR transcript is decreased by 67 %. The induction of A 2A AR mRNA by LPS is detectable after 1 h, reaches a peak at 6 h at 600 times control and remains elevated beyond 24 h. The ED 50 (effective dose) of LPS is 2.3 ng/ml. A 2A AR receptor number, measured by 125 I-ZM241385 binding to whole cells, is undetectable in naïve cells and increases linearly at a rate of 23 receptors · cell
INTRODUCTION
Adenosine released from stressed cells can act as a physiological inhibitor of inflammation [1] . Utilization of ATP during periods of high metabolic activity leads to an increased concentration of intracellular adenosine that can be transported across the cell membrane by nucleoside transporters. Adenine nucleotides also are released from stressed cells or necrotic cells or by degranulation of nerves, mast cells or platelets and are dephosphorylated to form adenosine by extracellular nucleotidases [2] . Adenosine acts at the cell surface through four G-protein-coupled adenosine receptors (ARs): A 1 , A 2A , A 2B and A 3 . These receptors each have a unique pharmacological and physiological profile that enables adenosine to stimulate a variety of effects depending on its concentration and the distribution of receptors in a given tissue [3] . The G s -coupled high-affinity A 2A AR mediates many anti-inflammatory actions of adenosine in a variety of cell types, including inhibition of neutrophil [4] , monocyte [5] , platelet [6] , and T-cell activation [7, 8] . In animal models, A 2A AR agonists can prevent death from bacterial LPS (lipopolysaccharide) or sepsis [9] . The G s /G q -coupled lowaffinity A 2B AR is thought to contribute an anti-inflammatory action of adenosine in macrophages [10] [11] [12] . The role of the G i/o -coupled A 1 AR and the A 3 AR in macrophages is not clear.
Bacterial LPS and inflammatory cytokines have been reported to induce a small (< 2-fold) increase in the expression of A 2A AR mRNA in human monocytic cell lines [13, 14] . Maturation of monocytes to macrophages is associated with increased expression and secretion of TNFα (tumour necrosis factor α) in response to inflammatory stimuli [15] . Macrophages pretreated with LPS have been noted to have an exaggerated response to A 2A AR agonists [16, 17] . In mouse IPM (peritoneal macrophages), LPS was found to elicit a 15-fold increase in mRNA for the A 2B AR [18] . Although macrophages provide an important defence against bacterial pathogens, their overactivation can cause damage to inflamed host tissues, and such overactivation may be prevented by adenosine. In order to further examine the regulation of adenosine receptors in macrophages, we have investigated the effects of LPS on the expression of mouse and human adenosine receptor mRNAs and receptor number. LPS causes a very strong induction of A 2A AR mRNA in macrophages and corresponding Abbreviations used: AR, adenosine receptor; ADA, adenosine deaminase; ATL146e, 4-{3-[6-amino-9-(5-ethylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-cyclohexanecarboxylic acid methyl ester; [19] was purchased from Tocris Cookson (Ellisville, MO, U.S.A.). Carrier-free 125 I-ZM241385 was synthesized and HPLC-purified as described in [20, 21] . ATL146e (4-{3-[6-amino-9-(5-ethylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-cyclohexanecarboxylic acid methyl ester) [22] 
Cell culture
Wehi-3 cells (A.T.C.C.) were grown in suspension at 0.2-1.0 × 10 6 cells/ml in Iscove's medium supplemented with 10 % (v/v) FBS (foetal bovine serum) and 5 mM 2-mercaptoethanol. Cultures were kept at 37
• C in a humidified incubator with 5 % CO 2 . All experiments used cells below passage 20.
IPM harvest
Balb/c mice injected with 2 ml of 39.8 g/l sterile thioglycolate solution were killed after 7 days. The peritoneal cavity was washed twice with 10 ml of PBS + 2 mM EDTA to make a cell suspension containing 3-6 × 10 5 cells/ml. After centrifugation at 300 g for 8 min, the cells were resuspended in medium and added to tissue-culture plates. After 3 h, non-adherent cells were removed and the adherent cells were washed with PBS. The resulting macrophage preparations were cultured in Dulbecco's modified Eagle's medium with high glucose, 10 % heat-inactivated FBS and penicillin/streptomycin for up to 48 h.
Human monocyte-derived macrophages
Peripheral venous blood was obtained from healthy adult volunteers with informed written consent. The blood was anticoagulated with heparin (10 units/ml), and the monocytes were enriched with Rosettesep TM according to the manufacturer's instructions. This isolation yielded approx. 5 × 10 6 monocytes (> 80 %)/10 ml of blood. By FACS, the cells had a phenotype of CD14 + , CD24 − and CD3 − . The monocytes (1-2 × 10 6 cells/ well) were cultured for 3 days in 24-well tissue-culture-treated plates (37
• C and 5% CO 2 ) in RPMI 1640 growth medium containing penicillin/streptomycin, 5 % (v/v) autologous serum and 10 ng/ml recombinant human macrophage colony-stimulating factor, resulting in macrophages expressing high non-specific esterase staining, high CD14 and low MHC Class II, consistent with a macrophage phenotype.
Quantitative PCR
Using the iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA, U.S.A.), cDNA was made from 1 µg of RNA, using mixed random and oligo-dT primers, following the manufacturer's instructions.
The reaction mixture was then diluted to the equivalent of 5 µg/ ml RNA, and 5 µl of the diluted mixture was incorporated into the quantitative-PCR reaction mixture. Quantitative PCR was performed using the Quantitect SYBR ® Green PCR kit (Qiagen, Valencia, CA, U.S.A.). A typical reaction contained 25 µl of the kit reaction mixture, 17 µl of molecular biology grade water, 1.5 µl each of 10 µM primer stocks and 5 µl of cDNA or plasmid standard. Standard curves were produced using diluted plasmids with known copy numbers of the gene of interest. Real-time PCR was performed using the iCycler iQ Real-Time PCR Detection System from Bio-Rad using the supplied software. The thermal cycler tracks fluorescence levels over 40 amplification cycles. A melt curve was performed at the end of each run to verify that there was a single amplification product and a lack of primer dimers. All samples were normalized to the amount of GAPDH (glyceraldehyde-3-phosphate dehydrogenase) or β-actin (human cells) mRNAs present in the sample. The relative amount of a given mRNA of interest was determined using the C T method [23] .
Primers for the real-time PCR were designed from sequences in GenBank ® database. The PCR primers were validated by sequencing the reaction products after TA-cloning (Invitrogen, Carlsbad, CA, U.S.A.). The following primers were used (forward, reverse): 
Radioligand binding
Wehi-3 or IPM cells were resuspended in PBS with 1.5 units/ml ADA at a concentration of 2 × 10 6 cells/ml. Aliquots (100 µl) of the cell suspensions were placed into wells of a 96-well Millipore Multiscreen ® GF/C filter plate. Various concentrations of the radiolabelled antagonist, 125 I-ZM241385 were added in 50 µl of PBS with 2 units/ml ADA. After incubating the assays at 4
• C for 2-3 h, binding reactions were terminated by rapid filtration on a cell harvester (Brandel, Gaithersburg, MD, U.S.A.) followed by 4 × 150 µl washes for 30 s with ice-cold 10 mM Tris/HCl (pH 7.4) and 10 mM MgCl 2 . Non-specific binding was measured in the presence of 50 µM NECA.
cAMP assays
Cells were removed from their media, washed twice by centrifugation with PBS and resuspended in PBS supplemented with 2 units/ml ADA at a concentration of 1 × 10 6 cells/ml. Aliquots (200 µl) of the cell suspension were added to 75 mm polypropylene tubes with 50 µl of 5 × ATL146e in various concentrations. All tubes received 50 µM rolipram. After incubation for 15 min at 37
• C, the reaction was stopped by the addition of 0.5 ml of 0.15 M HCl. The cells were pelleted by centrifugation and the supernatants were frozen for cAMP analysis by EIA (enzyme immunoassay; Assay Designs, Ann Arbor, MI, U.S.A.).
Measurement of TNFα concentration
IPM were resuspended in PBS supplemented with 2 units/ ml ADA at a concentration of 0.5 × 10 6 cells/ml. Cells were 
RESULTS

LPS rapidly changes adenosine receptor mRNAs in macrophages
Treatment of Wehi-3 cells, mouse macrophages or human macrophages with LPS evoked rapid and large changes in A 2A AR mRNA and smaller changes in mRNAs for the other adenosine receptor subtypes. Figure 1 shows the time-course and dose-response curve for A 2A AR mRNA induction in Wehi-3 cells. A 2A AR mRNA was increased by over 8-fold within 1 h and reached a peak above 600-fold in 6 h. LPS increased A 2A AR mRNA with an ED 50 of 2.3 ng/ml, with significant induction noted by 10 pg/ml (Figure 1B) . This up-regulation was almost completely inhibited by 30 µg/ml polymyxin B (results not shown). LPS elicited a smaller increase in A 2B AR transcript and a small decrease in A 3 AR transcript in both Wehi-3 cells and mouse IPM (Figure 2A) . A 1 AR mRNA expression did not change from the initial lowlevel expression in Wehi-3 cells and it was decreased in IPM . In human macrophages, mRNA in unstimulated cells was very low and strongly induced by LPS, resulting in a very high fold stimulation of A 2A AR mRNA.
Role of NF-κB (nuclear factor κB) in A 2A AR mRNA induction
NF-κB has been implicated as a mediator of cytokine induction in macrophages. We investigated the effects of the selective NF-κB inhibitor BAY 11-7082 on induction of A 2A AR mRNA and, as a positive control, on the induction of TNFα mRNA and protein in IPM . As shown in Figure 2 
Increased
I-ZM241385 binding to LPS-treated Wehi-3 cells
In order to determine if increased A 2A AR mRNA levels result in increased A 2A AR expression, we measured receptor number in Wehi-3 cells using the specific A 2A AR antagonist, 125 I-ZM241385. As seen in Figure 3(A) , there is no significant specific radioligand binding to vehicle-treated control cells. After treatment with 100 ng/ml LPS, the cells specifically bind 125 I-ZM241385 with a B max of 85 fmol/mg after 4 h, 150 fmol/mg after 8 h and 348 fmol/mg after 20 h. Figure 3(B) shows Scatchard transformations of these data, indicating binding to a single saturable site that does not change affinity as a result of receptor up-regulation. We determined that 1 µg of protein corresponds to 7500 Wehi-3 cells. On the basis of this calculation, the number of receptors/cell at 20 h is 28 000 and the receptor density increases at a linear rate of 23 receptors · cell −1 · min −1 for at least 20 h ( Figure 3C ). In order to determine whether the newly made A 2A ARs on Wehi-3 cells function normally, we measured cAMP levels in cells pretreated with or without 100 ng/ml LPS. Figure 3(D) shows that control cells did not have a significant cAMP response to the A 2A agonist ATL146e. In contrast, cells that had been treated overnight with LPS made significant amounts of cAMP in the presence of 10 nM ATL146e. This effect was inhibited by treatment with 50 nM ZM241385.
LPS-pretreated IPM s are more sensitive to an A 2A AR agonist
We also examined the effect of LPS on A 2A AR number on IPM . Since LPS has no effect on 125 I-ZM241385 affinity, we used a single concentration of radioligand. Figure 4 (A) shows that cells that had been pretreated with LPS overnight displayed over 20 times higher radioligand binding than control cells. In order to confirm the functional significance of A 2A AR up-regulation, we examined the sensitivity of these cells to A 2A AR-mediated inhibition of TNFα release in response to acute LPS treatment. Cells were treated overnight with or without (+ − ) 10 ng/ml LPS, washed with PBS, then rechallenged for 4 h with 10 ng/ml LPS and ATL146e at various doses. As seen in Figure 4 (B), the EC 50 for ATL146e in LPS-pretreated cells was 0.1 nM, approx. 200-fold more potent than the EC 50 in control cells (20 nM) .
DISCUSSION
TLRs (Toll-like receptors) on macrophages recognize microbial products (e.g. lipoproteins, peptidoglycan, LPS, flagellin and bacterial DNA) and initiate the transcription of many cytokines that promote phagocytosis in response to bacterial pathogens. The present study demonstrates that activation of macrophages with LPS also initiates a mechanism to terminate inflammation after a delay, by causing the induction of anti-inflammatory adenosine receptors A 2B and principally A 2A . There is also a reduction of G i -coupled A 1 and A 3 mRNAs that may also contribute to inactivation of macrophages exposed to adenosine after LPS. Changes in the macrophage response to adenosine may also be modulated by altered expression of the β-subunits of heterotrimeric G-proteins [24] [25] [26] . The magnitude of A 2A AR mRNA induction, > 100-fold in Wehi-3 cells, IPM and human macrophages, is far greater than the induction noted in the human monocyte-like THP-1 cell line and mouse endothelial cells [14, 26] . The large A 2A AR mRNA and protein induction may be an important adaptation to limit collateral damage to host tissues during infection. The activation of the G s -coupled A 2A AR in a variety of cell types leads to inhibition of pro-inflammatory pathways. A 2A AR activation inhibits aggregation in platelets [28] [29] [30] , inhibits adhesion and oxidative burst in neutrophils [4, 31] and decreases pro-inflammatory cytokines in monocytes [5, 32, 33] and macrophages [34, 35] . Genetic deletion of the A 2A AR gene, adora2a, leads to a hyperactive immune response after chemical or ischaemic liver injury, suggesting that the A 2A AR is an important endogenous anti-inflammatory pathway [1, 36] . Previous work from our group has shown that A 2A AR activation improves survival in murine models of endotoxaemia and sepsis [9] .
It is noteworthy that our findings demonstrate for the first time that the anti-inflammatory potency of A 2A AR activation is enhanced after inflammation due to the large induction of radioligand-binding sites and functional A 2A receptors. Hence, A 2A AR or A 2B AR agonists or adenosine are probably most effective as anti-inflammatory agents when administered during infection or other inflammatory conditions that provokes the induction of these receptors. The increase in A 2A AR mRNA and functional potency was associated with an increase in receptor density measured by radioligand binding. Leibovich and colleagues [16, 17] did not observe an increase in A 2A AR immunoreactivity by Western blotting following treatment of macrophages with LPS. Our experience is that radioligand binding is more sensitive and less prone to non-specific binding than Western blotting as a means to detect the A 2A AR. For example, some antibodies detect immunoreactive proteins near the molecular mass of the A 2A AR, even in tissues from mice in which the A 2A AR gene has been deleted [38] . No specific radioligand binding is detected in such mice. The results of the present study clearly demonstrate an increase in A 2A AR receptor density over time after exposure of Wehi-3 cells, IPM or human macrophages to LPS.
Pretreatment of IPM with the NF-κB inhibitor BAY 11-7082 inhibited the induction of A 2A AR and TNFα mRNAs. A role for NF-κB in the induction of cytokines, along with inhibition by BAY 11-7082, has been previously demonstrated in human macrophages [39] . The AP-1 family of transcription factors comprising the Jun, Fos, Maf and ATF subfamilies can be activated by LPS in macrophages to stimulate cytokine production [40, 41] . Analysis of the 5 -end of the adora2a gene by Fredholm et al. [42] shows a putative AP-1 binding site approx. 1 kb upstream of the transcriptional start site, suggesting that transcription of cytokines and A 2A ARs may be regulated by some of the same transcription factors.
In summary, we have shown that LPS rapidly and markedly increases the expression of A 2A AR mRNA in human and mouse macrophages. The newly formed receptors are functional as evidenced by A 2A AR agonist-stimulated cAMP accumulation, enhanced radioligand binding and an increased potency of an agonist to inhibit TNFα release from these cells. LPS causes a smaller increase in A 2B AR mRNAs and decreases A 1 and A 3 mRNA in mouse macrophages. The up-regulation of the A 2A AR may provide an endogenous and inducible anti-inflammatory pathway to limit the activity of the immune system in response to bacterial infection and other inflammatory stimuli.
